Single In-Clinic Encounter With the Notal Vision Home OCT

Completed

Conditions studied: Neovascular Age-related Macular Degeneration, Intermediate Age Related Macular Degeneration (Disorder)

In brief

this is a single In-Clinic Encounter With the Notal Vision Home OCT study. The study population will include up to 50 Age-related Macular Degeneration patients diagnosed with wet NV-AMD in at least one eye at the time of enrollment. All enrolled subjects should have at least one eye with active (wet) CNV (SRF and/or IRF) at the time of enrollment. All subjects will be enrolled at 1 site in the United States. in this study patients will be placed in a room with the Notal Vision Home OCT device and following a completion of a self tutorial will perform 3 unsupervised self-scans on each study eye (with a rest of \~5 minutes between self-scans). at the end of the testing sessions, the subject will be asked to complete subject user questionnaire.

Key facts

Study ID

NCT04642183

Run by

Notal Vision Inc.

People needed

70

Starts

2020-11-16

Expected to finish

2021-09-30

Last updated by the study team

2021-12-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ability to speak, read and understand English.
• Ability to understand and agree to contents of informed consent either in writing or verbally.
• Eighteen (18) years of age or older at the time of Informed Consent.
• AMD patients diagnosed with wet NV-AMD in at least one eye (ie, with SRF, and/or IRF).
• Fellow eye with NV-AMD (with or without fluid) or intermediate AMD.
• Best corrected Visual Acuity of 20/320 or better in eyes participating at the study.

You may not qualify if…

• Subjects with dilated pupils.
• Any other retinal disease requiring steroidal or anti-VEGF injections.

Where it is running

• Elman Retina Group, PA — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.